NEUROPACE, INC. Payments of Stock Issuance Costs
NEUROPACE, INC. (NPCE) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-03-04
- NEUROPACE, INC. payments of stock issuance costs for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. payments of stock issuance costs for the quarter ending 2024-09-30 was $0.00.
- NEUROPACE, INC. payments of stock issuance costs for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. payments of stock issuance costs for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- NEUROPACE, INC. payments of stock issuance costs for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- NEUROPACE, INC. payments of stock issuance costs for fiscal 2023 was $305.00K, a 12.10% decline from fiscal 2022.
- NEUROPACE, INC. payments of stock issuance costs for fiscal 2022 was $347.00K, a 89.77% decline from fiscal 2021.
- NEUROPACE, INC. payments of stock issuance costs for fiscal 2021 was $3.39M, a 1515.24% increase from fiscal 2020.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $0.00 derived: sum of 2 quarters · filed 2025-03-04 | $0.00 derived: sum of 3 quarters · filed 2025-03-04 | $0.00 10-K · filed 2025-03-04 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $186.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $186.00K derived: sum of 3 quarters · filed 2025-03-04 | $186.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | $186.00K derived: sum of 2 quarters · filed 2025-03-04 | $186.00K derived: sum of 3 quarters · filed 2025-03-04 | $195.00K derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-12-31 | $186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $186.00K derived: sum of 2 quarters · filed 2025-03-04 | $195.00K derived: sum of 3 quarters · filed 2025-03-04 | $305.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $9.00K derived: sum of 2 quarters · filed 2024-11-12 | $119.00K 10-Q · filed 2024-11-12 | $466.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $119.00K 10-Q · filed 2024-08-13 | $466.00K derived: sum of 3 quarters · filed 2024-08-13 | $466.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $110.00K 10-Q · filed 2024-05-08 | $457.00K derived: sum of 2 quarters · filed 2024-05-08 | $457.00K derived: sum of 3 quarters · filed 2024-05-08 | $457.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $347.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $347.00K derived: sum of 2 quarters · filed 2024-03-05 | $347.00K derived: sum of 3 quarters · filed 2024-03-05 | $347.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $0.00 derived: sum of 2 quarters · filed 2023-11-06 | $0.00 10-Q · filed 2023-11-06 | $0.00 derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $0.00 derived: sum of 3 quarters · filed 2023-08-08 | $0.00 derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2023-05-04 | $0.00 derived: sum of 3 quarters · filed 2023-05-04 | $1.81M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $1.81M derived: sum of 3 quarters · filed 2023-03-02 | $3.39M 10-K · filed 2023-03-02 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.81M derived: sum of 2 quarters · filed 2022-11-08 | $3.39M 10-Q · filed 2022-11-08 | $3.60M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $3.39M 10-Q · filed 2022-08-11 | $3.60M derived: sum of 3 quarters · filed 2022-08-11 | $3.48M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.58M 10-Q · filed 2022-05-12 | $1.79M derived: sum of 2 quarters · filed 2022-05-12 | $1.68M derived: sum of 3 quarters · filed 2022-05-12 | $1.79M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $93.00K derived: sum of 2 quarters · filed 2022-03-10 | $210.00K derived: sum of 3 quarters · filed 2022-03-10 | $210.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | -$117.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $117.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $117.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |